David W. Harden, MD
NPI 1134184245ActiveIndividual· Dermatology· Garden City, KS
Dermatology (MD) in Garden City, Kansas, trained at University of Kansas School of Med (Kc/Wich/Sal) (class of 1993). 1,483 Medicare patients in 2024, $310,940 paid; nearly all of their 837 Part D prescriptions were generic (94%). Abbvie Inc. was the largest of 17 companies reporting payments in 2025, $1,739 in all, mostly food and beverage.
Overview
| NPI | 1134184245 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Apr 20, 2006 |
| Last updated in NPPES | Jan 14, 2026 |
| Certified by provider | Jan 14, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Dermatology Primary | 207N00000X | 0425336 | KS |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 1,483 |
|---|---|
| Services billed | 8,775 across 76 procedure codes |
| Paid by Medicare | $310,940 |
Part D prescriptions in 2024
| Prescriptions (claims) | 837 · 887 30-day fills |
|---|---|
| Patients | 408 |
| Total drug cost | $156,594 |
| Generic share | 94% of claims |
Education and affiliations
| Medical school | University of Kansas School of Med (Kc/Wich/Sal) |
|---|---|
| Graduation year | 1993 |
| Medicare specialty | Dermatology |
Industry payments (Open Payments)
- 2025$1,739 · 91 payments from 17 companies
- 2024$1,785 · 95 payments from 17 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Abbvie Inc. | $355.45 | 21 |
| Novartis Pharmaceuticals Corporation | $293.09 | 14 |
| E.R. Squibb & Sons, L.L.C. | $241.26 | 15 |
| Janssen Biotech, Inc. | $149.96 | 9 |
| Genzyme Corporation | $141.78 | 5 |
What the 2025 payments were for
- Food and Beverage$1,739 · 91 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records